Thursday, December 2, 2021

Tag: Pharmaceutical

Emerging Growth Pharmaceutical Companies

Why 2021 Is the Year to Invest in Cannabis

Looking at three US cannabis companies, the author notes that growth among these companies significantly outpaced the S&P 500. The companies noted include Green Thumb Industries (OTC:GTBIF) and Cresco Labs (OTC:CRLBF), who saw significant growth in their home state of Illinois, and Trulieve Cannabis (OTC:TCNNF), which has a strong foothold in Florida’s medical cannabis industry.

Trending Cannabis Stocks as Legalization Talks Continue

Companies like Village Farms International (NASDAQ:VFF), a greenhouse agriculture giant, and real estate developer Innovative Industrial Properties Inc. (NYSE:IIPR) are expanding into the industry as well. Similarly, not all companies focus on the psychoactive plant that is the primary focus of legalization - companies like Charlotte’s Web (OTCMKTS:CWBHF) focus on non-psychoactive, therapeutic products that have also seen growing interest.

Cannabis Stocks with Incredible Promise in 2021

Among the companies mentioned by the author were Cresco Labs (OTC:CRLBF), who currently operates in 9 states and is positioned to enter additional markets with strategic acquisitions later this year. The writer notes another multi-state operator that currently operates in 12 states - Green Thumb Industries (OTC:GTBIF), which also has an eye toward new markets and partnerships. Finally, the author notes Jushi Holdings (OTC:JUSHF), which currently operates 16 retail locations across 4 states.

The Great Divide Between US and Canadian Cannabis Stocks

On the flip side, American companies, such as Curaleaf (OTC:CRLF), Cresco Labs (OTC:CRLBF), and Trulieve (OTC:TCNNF) have had to trade in more limited OTC markets. Despite this, demand for cannabis in the US is poised to outpace the Canadian market once federal legalization occurs, unleashing pent up investor demand simultaneously. If the SAFE Banking Act were to allow US-based cannabis companies to trade on major exchanges, Canadian companies may lose their premium placement currently enjoyed.

American Cannabis (AMMJ) Executes Definitive Agreement to Acquire Naturaleaf™ in Southern...

American Cannabis (AMMJ) Executes Definitive Agreement to Acquire Naturaleaf™ in Southern Colorado

A Marriage of HealthTech and FinTech in a Biotech driven Economy

Currently, the analyst consensus on Avadel Pharmaceuticals is a Strong Buy with an average price target of $20.25, a 167.9% upside from current levels. In a report issued on March 1, Oppenheimer also maintained a Buy rating on the stock with a $19.00 price target

Corporate Moves That Moved the Cannabis Needle Last Week

Further developments are also taking place in the Southwest through companies such as CLS Holdings USA, Inc. (OTCQB:CLSH;CSE:CLSH). CLS Holdings USA, Inc. (OTCQB: CLSH; CSE:CLSH) is a vertically integrated cannabis producer and retailer offering a wide variety of cannabis products through two subsidiaries: Oasis Cannabis and City Trees. The Company holds a U.S. Patent for a proprietary extraction and conversion methodology, which delivers products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting

Legalization in Mexico Spikes Cannabis Stocks

While more nations are passing federal cannabis legalization, the process is still piecemeal in the United States, where companies like CLS Holdings USA, Inc. (OTCQB:CLSH;CSE:CLSH) stand to be big winners. CLS Holdings USA, Inc. (OTCQB: CLSH; CSE:CLSH) is a vertically integrated cannabis producer and retailer offering a wide variety of cannabis products through two subsidiaries: Oasis Cannabis and City Trees. The Company holds a U.S. Patent for a proprietary extraction and conversion methodology, which delivers products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting.

Cannabis Stocks that Surge in February

Among these ten were MedMen Enterprises (NASDAQOTCBB:MMNFF), which rose 208%, OrganiGram Holdings (NASDAQ:OGI), which rose 66%, and Sundial Growers (NASDAQ:SNDL), which rose 63%. The author notes three primary catalysts that may have impacted growth across the sector - retail investors’ growing interest in inexpensive stocks, excitement building around the potential for US legalization, and increasing amount of merger and acquisition activity.

Epazz, Inc. (OTC Pink: EPAZ) Bitcoin Wallet Released & gets 10,000...

Miami, FL--(Emerging Growth NewsWire – March 11, 2021) – EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled...